Subsequently, Jong et al. [40] and Kleivi et al. [41] performed CGH analysis in relation to TP53 status on breast cancer specimens and confirmed a higher degree of abnormalities in patients carrying TP53 mutation, compared to those with wild type p53. The gene discussed is TP53; the disease is breast cancer.